Approaches to vaccines against Orientia tsutsugamushi

Keyphrases

• Antibiotic Treatment 33%
• Asia 33%
• Australia 33%
• Chronic Infection 33%
• Clinical Presentation 33%
• Commercially Available 33%
• Conserved Genes 33%
• Delayed Antibiotics 33%
• Diagnostic Test 33%
• Empirical Testing 33%
• Endothelial Cells 33%
• Fatality 33%
• Febrile Cases 33%
• Hospitalization 33%
• Immune Response 33%
• Immunogenicity 33%
• Immunological Challenge 33%
• Intracellular Bacteria 66%
• Mites 33%
• Number of Patients 33%
• Orientia 66%
• Orientia Tsutsugamushi 100%
• Pacific Ocean 33%
• Prophylactic Vaccine 33%
• Rickettsia 33%
• Rural Areas 33%
• Scrub Typhus 100%
• Survivors 33%
• Systemic Infection 33%
• T Cell Immunity 33%
• Unknown Number 33%
• Vaccination History 33%
• Vaccine Development 33%
• Vasculature 33%
• World War II 33%

Immunology and Microbiology

• Adoptive Immunity 33%
• Face 33%
• Immune Response 33%
• Immunogenicity 33%
• Infection 100%
• Intracellular Bacterium 66%
• Orientia 66%
• Orientia tsutsugamushi 100%
• Rickettsia 33%
• T Cell 33%
• Vascularization 33%